Ming Jiang

Adaptive resistance in tumors to anti-PD-1 therapy through re-immunosuppression by upregulation of GPNMB expression.

Jingming Zhang, T-G Huang, K. Xie, 2021, International immunopharmacology.

SCALE-1: Safety and efficacy of short course neoadjuvant chemo-radiotherapy plus toripalimab for locally advanced resectable squamous cell carcinoma of esophagus.

Si Li, Bin-hui Ren, Lijun Zhao, 2022, Journal of Clinical Oncology.

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment

Lijun Zhao, C. Kong, Jian-hua Xu, 2023, Frontiers in Oncology.

Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial

Lijun Zhao, Yinan Wu, Xiang-zhi Zhu, 2024, Journal for ImmunoTherapy of Cancer.